Primary Record
Pristinamycin
- In stock
- 5,109 g
- Purity
- 99.5 %
- CAS
- 11006-76-1
Compound Identifiers & Properties
- CAS
- 11006-76-1
- PubChem CID
- 73160420
- SMILES
- CCC1C(=O)N2CCCC2C(=O)N(C(C(=O)N3CCC(=O)CC3C(=O)NC(C(=O)OC(C(C(=O)N1)NC(=O)C4=C(C=CC=N4)O)C)C5=CC=CC=C5)CC6=CC=CC=C6)C.CC1C=CC(=O)NCC=CC(=CC(CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)OC1C(C)C)O)C
- Canonical SMILES
- CC1=CC(O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)OC(C(C)C)C(C)C=CC(=O)NCC=C1.CCC1NC(=O)C(NC(=O)c2ncccc2O)C(C)OC(=O)C(c2ccccc2)NC(=O)C2CC(=O)CCN2C(=O)C(Cc2ccccc2)N(C)C(=O)C2CCCN2C1=O
Names & Synonyms
- Pristinamycin
- Virginiamycin
- Ostreogricina
- Ostreogrycine
- Ostreogrycinum
- Pristinamicina
- Pristinamycine
- Pristinamycinum
- Staphylomycin
- Streptogramin
- Virginiamicina
- Virginiamycina
- Virginiamycine
- Virginiamycinum
- Micamicina
- Mikamycine
- Mikamycinum
- Ostreogrycin
- Pyostacine
- Stapyocine
- Vernamycin
- Virgimycin
- Mikamycin
- Patricin
- Stafac
- Eskalin V
- Stafac 20
- Stafac 50
- Virginiamycin Complex
- Eskalin 500
- Virginiamycin (USAN
- Stafac 500
- Antibiotic No. 899
- Mikamycine [INN-French]
- Mikamycinum [INN-Latin]
- Micamicina [INN-Spanish]
- Ostreogrycine [INN-French]
- Ostreogrycinum [INN-Latin]
- Mikamycin [BAN:DCF:INN]
- UNII-C49WS9N75L
- Ostreogricina [INN-Spanish]
- Pristinamycine [INN-French]
- Pristinamycinum [INN-Latin]
- Virginiamycine [INN-French]
- Virginiamycinum [INN-Latin]
- Pristinamicina [INN-Spanish]
- Virginiamicina [INN-Spanish]
- Virginiamycina [INN-Spanish]
- V-MAX 50
- Virginiamycin [USAN:INN:BAN]
- HSDB 7033
- Virginiamycin - Activity - 50%
- BCP19339
- SKF 7988
- EINECS 234-244-6
- C71H84N10O17
- RP7293
- AV146007
- FT-0675831
- FT-0777859
- 11006-76-1
- 270076-60-3
- Pristinamycin;Staphylomycin;Mikamycine;RP 7293;RP-7293;RP7293;Pyostacine
- A mixture of two principal antibiotic components, virginiamycin M1 (Factor M1) and virginiamycin S1 (Factor S). Virginiamycin
- N-(3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl)-3-hydroxy-pyridine-2-carboxamide;21-hydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone
- N-(3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl)-3-hydroxypyridine-2-carboxamide;(12Z,17Z,19Z)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone